Crook J - Search Results

1

The utility of transition zone index in predicting acute urinary morbidity after 125I prostate brachytherapy.

Crook J, Toi A, McLean M, Pond G. Crook J, et al. Brachytherapy. 2002;1(3):131-7. doi: 10.1016/s1538-4721(02)00055-7. Brachytherapy. 2002. PMID: 15090275 Clinical Trial.

2

Proliferative cell nuclear antigen in postradiotherapy prostate biopsies.

Crook J, Robertson S, Esche B. Crook J, et al. Int J Radiat Oncol Biol Phys. 1994 Sep 30;30(2):303-8. doi: 10.1016/0360-3016(94)90008-6. Int J Radiat Oncol Biol Phys. 1994. PMID: 7928458

3

Prostate motion during standard radiotherapy as assessed by fiducial markers.

Crook JM, Raymond Y, Salhani D, Yang H, Esche B. Crook JM, et al. Radiother Oncol. 1995 Oct;37(1):35-42. doi: 10.1016/0167-8140(95)01613-l. Radiother Oncol. 1995. PMID: 8539455

4

Radiotherapy for localized prostate carcinoma. The correlation of pretreatment prostate specific antigen and nadir prostate specific antigen with outcome as assessed by systematic biopsy and serum prostate specific antigen.

Crook JM, Bahadur YA, Bociek RG, Perry GA, Robertson SJ, Esche BA. Crook JM, et al. Cancer. 1997 Jan 15;79(2):328-36. doi: 10.1002/(sici)1097-0142(19970115)79:2<328::aid-cncr16>3.0.co;2-2. Cancer. 1997. PMID: 9010106

5

Percent free prostate-specific antigen after radiotherapy for prostate cancer.

Crook JM, Bunting PS. Crook JM, et al. Urology. 1998 Jul;52(1):100-5. doi: 10.1016/s0090-4295(98)00119-8. Urology. 1998. PMID: 9671878

6

Postradiotherapy prostate biopsies: what do they really mean? Results for 498 patients.

Crook J, Malone S, Perry G, Bahadur Y, Robertson S, Abdolell M. Crook J, et al. Int J Radiat Oncol Biol Phys. 2000 Sep 1;48(2):355-67. doi: 10.1016/s0360-3016(00)00637-4. Int J Radiat Oncol Biol Phys. 2000. PMID: 10974448

7

Systematic overview of the evidence for brachytherapy in clinically localized prostate cancer.

Crook J, Lukka H, Klotz L, Bestic N, Johnston M; Genitourinary Cancer Disease Site Group of the Cancer Care Ontario Practice Guidelines Initiative. Crook J, et al. CMAJ. 2001 Apr 3;164(7):975-81. CMAJ. 2001. PMID: 11314451 Free PMC article.

8

The effect of seed orientation deviations on the quality of 125I prostate implants.

Corbett JF, Jezioranski JJ, Crook J, Tran T, Yeung IW. Corbett JF, et al. Among authors: crook j. Phys Med Biol. 2001 Nov;46(11):2785-800. doi: 10.1088/0031-9155/46/11/303. Phys Med Biol. 2001. PMID: 11720347

9

Interstitial brachytherapy for penile cancer: an alternative to amputation.

Crook J, Grimard L, Tsihlias J, Morash C, Panzarella T. Crook J, et al. J Urol. 2002 Feb;167(2 Pt 1):506-11. doi: 10.1016/S0022-5347(01)69074-8. J Urol. 2002. PMID: 11792907

10

Factors influencing risk of acute urinary retention after TRUS-guided permanent prostate seed implantation.

Crook J, McLean M, Catton C, Yeung I, Tsihlias J, Pintilie M. Crook J, et al. Int J Radiat Oncol Biol Phys. 2002 Feb 1;52(2):453-60. doi: 10.1016/s0360-3016(01)02658-x. Int J Radiat Oncol Biol Phys. 2002. PMID: 11872292

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

741 results

Search Page

Filters